Literature DB >> 21277709

No evidence of association between 118A>G OPRM1 polymorphism and heroin dependence in a large Bulgarian case-control sample.

Momchil A Nikolov1, Olga Beltcheva, Antoaneta Galabova, Anna Ljubenova, Elena Jankova, Galin Gergov, Atanas A Russev, Michael T Lynskey, Elliot C Nelson, Eleonora Nesheva, Dorita Krasteva, Philip Lazarov, Vanio I Mitev, Ivo M Kremensky, Radka P Kaneva, Alexandre A Todorov.   

Abstract

The μ-opioid receptor is the primary site of action of most opioids. The 118A>G (rs1799971) polymorphism in exon 1 of the μ-opioid receptor gene (OPRM1) leads to an Asn40Asp amino acid change that affects a putative N-glycosylation site. It has been widely investigated for association with alcohol and drug dependence and pain sensitivity, with mixed results. The aim of the current study was to examine whether this polymorphism was associated with heroin dependence in a large Bulgarian cohort of 1842 active users and 1451 population controls. SNP genotyping was done using Real-Time PCR TaqMan technology. Association analyses were conducted, separately for Roma and non-Roma participants. Our results suggest that there is no direct effect of 118A>G genotype on the risk for heroin dependence among active heroin users.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21277709      PMCID: PMC3128690          DOI: 10.1016/j.drugalcdep.2010.12.026

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  30 in total

1.  Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations.

Authors:  Ene-Choo Tan; Chay-Hoon Tan; Umavathy Karupathivan; Eric P H Yap
Journal:  Neuroreport       Date:  2003-03-24       Impact factor: 1.837

2.  Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

Authors:  Ying Zhang; Danxin Wang; Andrew D Johnson; Audrey C Papp; Wolfgang Sadée
Journal:  J Biol Chem       Date:  2005-07-26       Impact factor: 5.157

3.  Mu opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers.

Authors:  Katarina Drakenberg; Andrej Nikoshkov; Monika Cs Horváth; Pernilla Fagergren; Anna Gharibyan; Kati Saarelainen; Sadia Rahman; Ingrid Nylander; Georgy Bakalkin; Jovan Rajs; Eva Keller; Yasmin L Hurd
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

4.  Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence.

Authors:  Huiping Zhang; Xingguang Luo; Henry R Kranzler; Jaakko Lappalainen; Bao-Zhu Yang; Evgeny Krupitsky; Edwin Zvartau; Joel Gelernter
Journal:  Hum Mol Genet       Date:  2006-02-13       Impact factor: 6.150

Review 5.  Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment.

Authors:  Vadim Yuferov; Orna Levran; Dmitri Proudnikov; David A Nielsen; Mary Jeanne Kreek
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

6.  The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans.

Authors:  Roger B Fillingim; Lee Kaplan; Roland Staud; Timothy J Ness; Toni L Glover; Claudia M Campbell; Jeffrey S Mogil; Margaret R Wallace
Journal:  J Pain       Date:  2005-03       Impact factor: 5.820

7.  Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts.

Authors:  C Y Szeto; N L Tang; D T Lee; A Stadlin
Journal:  Neuroreport       Date:  2001-05-08       Impact factor: 1.837

8.  Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.

Authors:  C Bond; K S LaForge; M Tian; D Melia; S Zhang; L Borg; J Gong; J Schluger; J A Strong; S M Leal; J A Tischfield; M J Kreek; L Yu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

9.  Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations.

Authors:  Ke Xu; Dirk Lichtermann; Robert H Lipsky; Petra Franke; Xiehe Liu; Ying Hu; Liping Cao; Sibylle G Schwab; Dieter B Wildenauer; Claiton H D Bau; Erica Ferro; Will Astor; Thembi Finch; Jeanietta Terry; Julie Taubman; Wolfgang Maier; David Goldman
Journal:  Arch Gen Psychiatry       Date:  2004-06

10.  Genetic susceptibility to heroin addiction: a candidate gene association study.

Authors:  O Levran; D Londono; K O'Hara; D A Nielsen; E Peles; J Rotrosen; P Casadonte; S Linzy; M Randesi; J Ott; M Adelson; M J Kreek
Journal:  Genes Brain Behav       Date:  2008-06-02       Impact factor: 3.449

View more
  13 in total

Review 1.  Pharmacogenetics of OPRM1.

Authors:  Richard C Crist; Wade H Berrettini
Journal:  Pharmacol Biochem Behav       Date:  2013-11-05       Impact factor: 3.533

Review 2.  Genetics of opiate addiction.

Authors:  Brian Reed; Eduardo R Butelman; Vadim Yuferov; Matthew Randesi; Mary Jeanne Kreek
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

Review 3.  Molecular Genetics and New Medication Strategies for Opioid Addiction.

Authors:  Yasmin L Hurd; Charles P O'Brien
Journal:  Am J Psychiatry       Date:  2018-08-02       Impact factor: 18.112

4.  Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts.

Authors:  Tae-Hwi Schwantes-An; Juan Zhang; Li-Shiun Chen; Sarah M Hartz; Robert C Culverhouse; Xiangning Chen; Hilary Coon; Josef Frank; Helen M Kamens; Bettina Konte; Leena Kovanen; Antti Latvala; Lisa N Legrand; Brion S Maher; Whitney E Melroy; Elliot C Nelson; Mark W Reid; Jason D Robinson; Pei-Hong Shen; Bao-Zhu Yang; Judy A Andrews; Paul Aveyard; Olga Beltcheva; Sandra A Brown; Dale S Cannon; Sven Cichon; Robin P Corley; Norbert Dahmen; Louisa Degenhardt; Tatiana Foroud; Wolfgang Gaebel; Ina Giegling; Stephen J Glatt; Richard A Grucza; Jill Hardin; Annette M Hartmann; Andrew C Heath; Stefan Herms; Colin A Hodgkinson; Per Hoffmann; Hyman Hops; David Huizinga; Marcus Ising; Eric O Johnson; Elaine Johnstone; Radka P Kaneva; Kenneth S Kendler; Falk Kiefer; Henry R Kranzler; Ken S Krauter; Orna Levran; Susanne Lucae; Michael T Lynskey; Wolfgang Maier; Karl Mann; Nicholas G Martin; Manuel Mattheisen; Grant W Montgomery; Bertram Müller-Myhsok; Michael F Murphy; Michael C Neale; Momchil A Nikolov; Denise Nishita; Markus M Nöthen; John Nurnberger; Timo Partonen; Michele L Pergadia; Maureen Reynolds; Monika Ridinger; Richard J Rose; Noora Rouvinen-Lagerström; Norbert Scherbaum; Christine Schmäl; Michael Soyka; Michael C Stallings; Michael Steffens; Jens Treutlein; Ming Tsuang; Tamara L Wall; Norbert Wodarz; Vadim Yuferov; Peter Zill; Andrew W Bergen; Jingchun Chen; Paul M Cinciripini; Howard J Edenberg; Marissa A Ehringer; Robert E Ferrell; Joel Gelernter; David Goldman; John K Hewitt; Christian J Hopfer; William G Iacono; Jaakko Kaprio; Mary Jeanne Kreek; Ivo M Kremensky; Pamela A F Madden; Matt McGue; Marcus R Munafò; Robert A Philibert; Marcella Rietschel; Alec Roy; Dan Rujescu; Sirkku T Saarikoski; Gary E Swan; Alexandre A Todorov; Michael M Vanyukov; Robert B Weiss; Laura J Bierut; Nancy L Saccone
Journal:  Behav Genet       Date:  2015-09-21       Impact factor: 2.805

5.  T394A Mutation at the μ Opioid Receptor Blocks Opioid Tolerance and Increases Vulnerability to Heroin Self-Administration in Mice.

Authors:  Xiao-Fei Wang; Elisabeth Barbier; Yi-Ting Chiu; Yi He; Jia Zhan; Guo-Hua Bi; Hai-Ying Zhang; Bo Feng; Lee-Yuan Liu-Chen; Jia Bei Wang; Zheng-Xiong Xi
Journal:  J Neurosci       Date:  2016-10-05       Impact factor: 6.167

Review 6.  The genetics of substance dependence.

Authors:  Jen-Chyong Wang; Manav Kapoor; Alison M Goate
Journal:  Annu Rev Genomics Hum Genet       Date:  2012-06-11       Impact factor: 8.929

Review 7.  Pharmacogenomics of Pain Management: The Impact of Specific Biological Polymorphisms on Drugs and Metabolism.

Authors:  Elyse M Cornett; Michelle A Carroll Turpin; Allison Pinner; Pankaj Thakur; Tamizh Selvan Gnana Sekaran; Harish Siddaiah; Jasmine Rivas; Anna Yates; G Jason Huang; Anitha Senthil; Narjeet Khurmi; Jenna L Miller; Cain W Stark; Richard D Urman; Alan David Kaye
Journal:  Curr Oncol Rep       Date:  2020-02-06       Impact factor: 5.075

Review 8.  A review of opioid addiction genetics.

Authors:  Richard C Crist; Benjamin C Reiner; Wade H Berrettini
Journal:  Curr Opin Psychol       Date:  2018-08-09

Review 9.  Molecular mechanisms of opioid receptor-dependent signaling and behavior.

Authors:  Ream Al-Hasani; Michael R Bruchas
Journal:  Anesthesiology       Date:  2011-12       Impact factor: 7.892

10.  Functional mu opioid receptor polymorphism (OPRM1 A(118) G) associated with heroin use outcomes in Caucasian males: A pilot study.

Authors:  Eric A Woodcock; Leslie H Lundahl; Margit Burmeister; Mark K Greenwald
Journal:  Am J Addict       Date:  2015-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.